Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
about
Inflammatory eye reactions with bisphosphonates and other osteoporosis medications: what are the risks?Current and emerging therapies for the treatment of osteoporosisCost-effectiveness of strontium ranelate for the prevention and treatment of osteoporosis.Overcoming problems with adherence to osteoporosis medication.Complications of thalassemia major and their treatment.New Target Sites for Treatment of Osteoporosis.Effects of Ethyl Acetate Extract of Poncirus trifoliata Fruit for Glucocorticoid-Induced Osteoporosis.Recommendations on the management of fragility fracture risk in women younger than 70 years.Local delivery of strontium ranelate promotes regeneration of critical size bone defects filled with collagen sponge.
P2860
Q27024738-D1A73756-6DF5-4C4E-ABDD-AFBB51FDB467Q36890431-FB8920F9-44C2-40EB-86DD-34A19487F9E9Q37780535-2CB154CC-71DA-4467-91E9-8DAFEC9502BAQ37820680-5D5CA62E-61EE-4F02-B8F4-5AAE2E53BA56Q37888721-0577AB6F-34E5-4178-9221-DBF9ED52EEBAQ39151180-D3ABD863-F29F-412E-A0BF-1AC3309AB825Q42182743-8CE06913-25D7-4A5B-BE9D-1C58275A5C34Q44278781-A3198803-37E0-4BE8-AB92-4C41EDBFBD33Q47187786-FFC20B12-5F03-4E58-ADBC-D0C17D1C7A7C
P2860
Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
@en
Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
@nl
type
label
Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
@en
Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
@nl
prefLabel
Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
@en
Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
@nl
P2093
P1433
P1476
Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
@en
P2093
Audrey Neuprez
Olivier Bruyere
Sophie Scholtissen
P2888
P304
P356
10.1007/S12325-008-0125-8
P407
P577
2008-12-01T00:00:00Z